Review of Optometry
Outlet metrics
Global
#237627
United States
#91402
Health/Medicine
#832
Articles
-
1 week ago |
reviewofoptometry.com | Clark Chang |Tracy Swartz
In the April 2025 issue of Review of Optometry—the magazine's 12th annual cornea report—learn effective strategies for managing herpetic keratitis, delve into advanced imaging techniques for early detection of keratoconus and get expert tips for specializing in advanced corneal care. Check out the other articles featured in this issue:My Patient Has Herpetic Keratitis… Now What?
-
1 week ago |
reviewofoptometry.com | Catlin Nalley
In the April 2025 issue of Review of Optometry—the magazine's 12th annual cornea report—learn effective strategies for managing herpetic keratitis, delve into advanced imaging techniques for early detection of keratoconus and get expert tips for specializing in advanced corneal care. Check out the other articles featured in this issue:My Patient Has Herpetic Keratitis… Now What?
-
1 week ago |
reviewofoptometry.com | Jack Persico
When you first identify a medical condition in a patient, you’re usually met with two strong emotions simultaneously: pride in your clinical acumen and, perhaps, anxiety over how to proceed. Suddenly, you’re on the hook to make a whole lot of judgment calls on the patient’s behalf. Should they begin therapy? If so, with what? How soon and how often should they be seen for follow-up? What criteria should you use to gauge success or failure of the treatment?
-
1 month ago |
reviewofoptometry.com | Catlin Nalley
Myopia is on the rise globally, with projections indicating that half of the world’s population will be affected by 2050. As prevalence increases, so does the need for specialized care to slow its progression and mitigate long-term ocular health risks. Optometrists who embrace myopia management have a unique opportunity to address a growing public health challenge while expanding their clinical expertise and practice offerings through evidence-based interventions that make a lasting impact.
-
1 month ago |
reviewofoptometry.com | Jack Persico
Another day, another Ozempic article. Ever since last summer, when JAMA Ophthalmology published worrisome findings showing an increased risk of NAION in patients using semaglutide, the active ingredient in Ozempic and Wegovy, additional studies have been coming fast and furious—and they often contradict each other. Here’s a timeline to catch you up. In July 2024, Harvard researchers published an observational study involving 555 patients taking semaglutide for either weight loss or diabetes.
Review of Optometry journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://reviewofoptometry.com/Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →